White Papers

  1. Why EHR Data Is The Game Changer For Life Sciences Success 5/26/2025

    The pharmaceutical industry faces soaring costs and shrinking ROI. Discover why leveraging rich real-world data is now essential for driving efficiency, innovation, and competitive advantage.

  2. How AI Is Unlocking Healthcare Data To Transform Prostate Cancer Treatment 5/22/2025

    As the global reliance on algorithms and artificial intelligence (AI) continues to grow, the importance of data quality and completeness has become a critical concern.

  3. The Transformative Power For Non-Muscle Invasive Bladder Cancer Treatment 5/20/2025

    Integrating AI with real-world urology data revolutionizes non-muscle invasive bladder cancer care to enable deeper insights into disease patterns, treatment outcomes, and personalized therapies.

  4. IPF - Global Clinical Trial Landscape 5/19/2025

    This report provides a comprehensive overview of Idiopathic Pulmonary Fibrosis (IPF), a progressive and fatal interstitial lung disease.

  5. Accelerate Drug Development With Master Protocols 5/15/2025

    Through careful planning, aligned incentives, and an open, adaptive mindset, master protocols become powerful engines for accelerating therapies to market—particularly in high-need therapeutic areas.

  6. A Strategic Guide For Biotech And Biopharma Leaders 5/15/2025

    Securing drug approval is a complex, high-stakes process, and outdated review workflows hinder progress. Explore modern solutions that accelerate timelines without compromising compliance or quality.

  7. Infectious Diseases - Global Clinical Trial Landscape (2025) 5/14/2025

    The global infectious disease clinical trial landscape has rapidly expanded between 2020 and 2024, driven by the urgency of emerging threats, technological innovation, and evolving regulatory frameworks.

  8. Obesity - Global Clinical Trial Landscape (2025) 5/14/2025

    This report analyzes the current state of global and Asia-Pacific obesity trials, highlighting regional trends, sponsor activity, and preferred endpoints.

  9. How Early-Stage Planning Strategies Are Optimizing Drug Development 5/12/2025

    Early integration of a target product profile (TPP) into early-stage planning is pivotal for steering drug development toward both regulatory success and commercial impact.

  10. Small Cell Lung Cancer- Global Clinical Trial Landscape (2025) 5/9/2025

    Historically dominated by chemotherapy and radiation, the treatment paradigm for small cell lung cancer (SCLC) is evolving in response to limited survival benefits and high relapse rates.